Ironwood Pharmaceuticals | IRWD - Assets


Ironwood Pharmaceuticals reported $396.06M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Acadia Pharmaceuticals USD 1.33B 105.22M Sep/2025
Agios Pharmaceuticals USD 1.39B 85.53M Sep/2025
Almirall EUR 2.31B 88.74M Jun/2025
Alnylam Pharmaceuticals USD 4.85B 285.64M Sep/2025
Amarin USD 659.81M 10.31M Sep/2025
Ardelyx USD 486.17M 19.4M Sep/2025
Astellas Pharma JPY 3.45T 114.46B Sep/2025
AstraZeneca USD 114.46B 2.03B Sep/2025
Charles River Laboratories USD 7.51B 46.73M Sep/2025
Exact Sciences USD 5.9B 102.64M Sep/2025
Halozyme Therapeutics USD 2.22B 167.33M Sep/2025
Incyte USD 6.33B 509M Sep/2025
Ironwood Pharmaceuticals USD 396.06M 53.12M Sep/2025
MacroGenics USD 270.76M 25.34M Sep/2025
Moderna USD 12.14B 125M Sep/2025
Myriad Genetics USD 728.1M 50.8M Sep/2025
Pacira USD 1.3B 239.68M Sep/2025
PTC Therapeutics USD 2.64B 9.54M Sep/2025
Sarepta Therapeutics USD 3.49B 186.38M Sep/2025
Takeda JPY 15.41T 938.47B Dec/2025
Ultragenyx Pharmaceutical USD 1.19B 115.82M Sep/2025